We further identified the key target is plasminogen-activating inhibitor-1 (PAI-1), which is the most up-regulated marker in the FOLFOX-induced SOS model and is required for nuclear factor-κB (NF-κB) activation in hepatocytes. The gene discussed is SERPINE1; the disease is spondylo-ocular syndrome.